TY  - CONF
AU  - Valentin, GG
AU  - Hernandez-Boluda, JC
AU  - Osorio, S
AU  - Correa, JG
AU  - Sanchez-Guijo, F
AU  - Gómez-Casares, MT
AU  - Durán, S
AU  - Portero, MA
AU  - Boqué, C
AU  - Pérez-Encinas, M
AU  - Mata, MI
AU  - Romo, MA
AU  - Vallansot, R
AU  - Payer, A
AU  - Noya, MS
AU  - Caballero, G
AU  - Ramirez Sánchez, MJ
AU  - Jimenez-Velasco, A
AU  - Steegmann, JL
PY  - 2016
SN  - 0390-6078
UR  - http://hdl.handle.net/10668/2441
T2  - Haematologica
AB  - Aims: The purpose of this study is to provide safety and efficacy informationfrom patients treated with ponatinib in real world clinical practice.
LA  - en
PB  - Ferrata Storti Foundation
KW  - Humanos
KW  - Imidazoles
KW  - Leucemia mielogenosa crónica BCR-ABL positiva
KW  - Piridacinas
KW  - Riesgo
KW  - Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans
KW  - Medical Subject Headings::Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds, 1-Ring::Azoles::Imidazoles
KW  - Medical Subject Headings::Diseases::Hemic and Lymphatic Diseases::Hematologic Diseases::Bone Marrow Diseases::Myeloproliferative Disorders::Leukemia, Myelogenous, Chronic, BCR-ABL Positive
KW  - Medical Subject Headings::Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds, 1-Ring::Pyridazines
KW  - Medical Subject Headings::Health Care::Health Care Quality, Access, and Evaluation::Quality of Health Care::Health Care Evaluation Mechanisms::Statistics as Topic::Probability::Risk
TI  - Safety and efficacy of ponatinib in real world clinical practice. Results from the Spanish Compassionate Use Program. A GELMC study
TY  - conference presentation
ER  -